Management of hypertension in the elderly: Looking for a trade-off between cardiovascular prevention and serious adverse events

Submitted: April 27, 2018
Accepted: May 11, 2018
Published: June 7, 2018
Abstract Views: 3011
PDF: 461
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Despite the effectiveness of anti-hypertensive therapy is well recognized, the most adequate target to achieve in the management of hypertension in the elderly is still under debate. Indeed, looking at the balance between benefits and risks, accumulating evidence has recently specifically addressed this issue, focusing on controversies. Evidence surrounding a more aggressive treatment may lead to a turnaround in the clinical care of older adult hypertensives, but a balanced trade-off between benefits and risks needs to be programmed and achieved, particularly in this clinical setting. We argue whether and how the results from recent trials could influence the management of hypertension in older people.



PlumX Metrics


Download data is not yet available.


How to Cite

Buonacera, Agata, Benedetta Stancanelli, and Lorenzo Malatino. 2018. “Management of Hypertension in the Elderly: Looking for a Trade-off Between Cardiovascular Prevention and Serious Adverse Events”. Monaldi Archives for Chest Disease 88 (2).